Commercial sales to begin this month, stock undervalued After 4 years as an R&D company, LXXGF finally starts commercial sales this month. Set to be a market leader in veterinary diagnostics. 1 hour PCR test results for the LexaGene MiQLab vs. 4-5 business days for sending to outside lab. COVID-19 testing turned out to be an unexpected bonus market. FDA EUA expected anytime from October to December 2020. Shares are undervalued now relative to the large markets that LXXGF will enter and win. https://seekingalpha.com/instablog/52496833-agni-research/5497965-lexagene-set-to-disrupt-veterinary-diagnostics-market From the stockhouse bullboard